Aravive Inc. (ARAV) Prices 3.33M Share Common Offering at $7.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
After-Hours Movers 11/26: (ONTX) (TNXP) (BOX) Higher; (ARAV) (ATHX) (GES) Lower (more...)
November 26, 2019 6:00 PM ESTAfter-Hours Movers
Onconova Therapeutic (NASDAQ: ONTX) 13.4% HIGHER; Steven Cohen's fund Point72 Asset Management, L.P. disclosed a 9.99%, or 3,230,434 share, stake in the company.
Aravive, Inc. (Nasdaq: ARAV) 13.3% LOWER; announced that it has commenced an underwritten public offering of the sale of its shares of common stock.
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.3% HIGHER; received the official minutes from the Breakthrough Therapy Type B Clinical... More
Aravive Inc. (ARAV) Plans Public Offering of Common Stock
November 26, 2019 5:14 PM ESTAravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis, today announced that it has commenced an underwritten public offering of the sale of its shares of common stock. In connection with... More
